304 related articles for article (PubMed ID: 28797460)
1. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
Rivera C; Oliveira AK; Costa RAP; De Rossi T; Paes Leme AF
Oral Oncol; 2017 Sep; 72():38-47. PubMed ID: 28797460
[TBL] [Abstract][Full Text] [Related]
2. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
4. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.
Elhousiny M; Miller K; Ariyawadana A; Nimmo A
Clin Exp Metastasis; 2019 Dec; 36(6):481-492. PubMed ID: 31559586
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis.
Min A; Zhu C; Peng S; Rajthala S; Costea DE; Sapkota D
Biomed Res Int; 2015; 2015():186904. PubMed ID: 26504785
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
[TBL] [Abstract][Full Text] [Related]
8. Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations.
Safi AF; Nickenig HJ; Rothamel D; Zirk M; Thiele O; Grandoch A; Scheer M; Zinser M; Zöller J; Drebber U; Kreppel M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1899-905. PubMed ID: 26447027
[TBL] [Abstract][Full Text] [Related]
9. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of cyclin D1 expression in oral squamous cell carcinoma: A systematic review and meta-analysis.
Ramos-García P; González-Moles MÁ; González-Ruiz L; Ruiz-Ávila I; Ayén Á; Gil-Montoya JA
Oral Oncol; 2018 Aug; 83():96-106. PubMed ID: 30098785
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.
de Vicente JC; Peña I; Rodrigo JP; Rodríguez-Santamarta T; Lequerica-Fernández P; Suárez-Fernández L; Allonca E; García-Pedrero JM
Head Neck; 2017 Sep; 39(9):1876-1887. PubMed ID: 28675642
[TBL] [Abstract][Full Text] [Related]
13. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
14. High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin YM; Sung WW; Hsieh MJ; Tsai SC; Lai HW; Yang SM; Shen KH; Chen MK; Lee H; Yeh KT; Chen CJ
PLoS One; 2015; 10(11):e0142656. PubMed ID: 26562534
[TBL] [Abstract][Full Text] [Related]
15. MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.
Valverde LF; de Freitas RD; Pereira TA; de Resende MF; Agra IMG; Dos Santos JN; Dos Reis MG; Sales CBS; Gurgel Rocha CA
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):120-125. PubMed ID: 27258565
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the immunohistochemical detection of cancer-associated fibroblasts in oral cancer: A systematic review and meta-analysis.
Dourado MR; Guerra ENS; Salo T; Lambert DW; Coletta RD
J Oral Pathol Med; 2018 May; 47(5):443-453. PubMed ID: 28782893
[TBL] [Abstract][Full Text] [Related]
18. Keratins 17 and 19 expression as prognostic markers in oral squamous cell carcinoma.
Coelho BA; Peterle GT; Santos M; Agostini LP; Maia LL; Stur E; Silva CV; Mendes SO; Almança CC; Freitas FV; Borçoi AR; Archanjo AB; Mercante AM; Nunes FD; Carvalho MB; Tajara EH; Louro ID; Silva-Conforti AM
Genet Mol Res; 2015 Nov; 14(4):15123-32. PubMed ID: 26634475
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
20. Stromal expression of neutrophil gelatinase-associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma.
Shinriki S; Jono H; Ueda M; Obayashi K; Nakamura T; Ota K; Ota T; Sueyoshi T; Guo J; Hayashi M; Hiraki A; Nakayama H; Yamashita S; Shinohara M; Ando Y
Histopathology; 2014 Feb; 64(3):356-64. PubMed ID: 24118080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
